Recalls & Warnings August 01, 2013 Maker of Algae Products Warned For Drug Claims, Manufacturing Violations On March 8, 2013, the FDA issued a warning letter to Algaen Corporation following a facility inspection and website review which found statements made about the company's AlgaBerry products to be drug claims
Diabetologia 59 (5), 954965
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohns disease
Conclusions GLP-1 RAs appear to elevate bioavailable testosterone and improve glycemic control, while effects on free testosterone and SHBG remain inconclusive
Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes2024
There were no differences in baseline asthma severity across the groups and no differences in routine asthma care encounters during this time